Glutamine solution in the parenteral nutrition for children with critical conditions

Cover Page

Cite item

Full Text

Abstract

Nutritional support for children with critical conditions is currently considered as the most important factor in the complex of therapy, which can prevent catabolism and risk of postoperative complications. Underestimation of the nutritional factor can lead to poor outcomes, such as a decrease in immunological resistance and the occurrence of postoperative complications.

Acute trauma in critically ill patients is characterized by metabolic and systemic responses, including an immune-inflammatory response that leads to immunosuppression and nosocomial infections. Parenteral nutrition is prescribed for patients in the intensive care unit who cannot be fed naturally to provide protein and energy substrates because of impaired homeostasis. The active use of arginine, glutamine, and omega-3 fatty acids is mainly indicated for patients with injuries and burns. Moreover, the discussion about the use of immune nutrition (arginine, glutamine, and omega-3 fatty acids) continues given the need for active use in intensive care. The article provides a review of the literature on the use of glutamine solution in parenteral nutrition for children. The article discusses modern approaches to prescribing parenteral nutrition with the additional use of glutamine solution, which has beneficial effects on the child’s body — increases the absorption function of the intestine, increases the thickness of the intestinal mucosa, helps maintain the morphological integrity of the intestine, and reduces intestinal permeability. Recent meta-analyses have shown the effect of glutamine-rich diets especially in patients with critical conditions. The addition of glutamine improves cellular processes and functioning of organs and systems. This leads to an improvement in immune competence, barrier function, and cessation of the inflammatory process. It is also a substrate for the formation of nitrite oxide and improves the formation of adenosine triphosphate in cells. Glutamine is an energy substrate for proliferative cells, including lymphocytes. In general, glutamine has a positive effect on many organs and systems, including the gastrointestinal systems, kidneys, lungs, heart, and liver. Immune nutrition has an anti-inflammatory effect, which helps prevent the development of acute phase response. In addition, it restores the indicators of protein metabolism in the early stages of parenteral nutrition. Therefore, the use of glutamine solution in total or complementary parenteral nutrition programs can optimize the quality of treatment for children.

About the authors

Yulia V. Erpuleva

G.N. Speransky Children’s Hospital No. 9

Author for correspondence.
Email: dgkb9@zdrav.mos.ru

Dr. Sci. (Med.)

Russian Federation, 29, Shmitovsky proezd, 123317, Moscow

References

  1. Erpuleva YuV, Kucherov YuI, Adleiba SR. Glutamine solution in parenteral nutrition in patients with surgical pathology. Russian journal of pediatric surgery, anesthesia and intensive care. 2018;8(3):60–66. (In Russ.) doi: 10.30946/2219-4061-2018-8-3-60-66.
  2. Zhou P, Li Y, Ma LY, Lin HC. The Role of Immunonutrients in the Prevention of Necrotizing Enterocolitis in Preterm Very Low Birth Weight Infants. Nutrients. 2015;7(9):7256–7270. doi: 10.3390/nu7095334
  3. Bober-Olesińska K, Kornacka MK. Effects of glutamine supplemented parenteral nutrition on the incidence of necrotizing enterocolitis, nosocomial sepsis and length of hospital stay in very low birth weight infants. Med Wieku Rozwoj. 2005;9(3-1):325–333. (In Polish).
  4. Brosnan JT. Interorgan amino acid transport and its regulation. J Nutr. 2003;133(6-1):2068S–2072S. doi: 10.1093/jn/133.6.2068S
  5. Mok E, Hankard R. Glutamine supplementation in sick children: is it beneficial? J Nutr Metab. 2011;61(5):97–148. doi: 10.1155/2011/617597
  6. Poindexter BB, Ehrenkranz RA, Stoll BJ, et al. Parenteral glutamine supplementation does not reduce the risk of mortality or late-onset sepsis in extremely low birth weight infants. Pediatrics. 2004;113(5):1209–1215. doi: 10.1542/peds.113.5.1209
  7. Lacey JM, Crouch JB, Benfell K, et al. The effects of glutamine-supplemented parenteral nutrition in premature infants. JPEN J Parenter Enteral Nutr. 1996;20(1):74–80. doi: 10.1177/014860719602000174
  8. Moe-Byrne T, Brown JV, McGuire W. Glutamine supplementation to prevent morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2016;4(4):CD001457. doi: 10.1002/14651858.CD001457
  9. El-Shimi MS, Awad HA, Abdelwahed MA, et al. Enteral L-Arginine and Glutamine Supplementation for Prevention of NEC in Preterm Neonates. Int J Pediatr. 2015;2015:856091. doi: 10.1155/2015/856091
  10. Lekmanov AU, Erpuleva YuV, Zolkina IV, Rossaus PA. Study of glutamine solution use efficiency in pediatric patients with heavy thermic burns and concomitant injuries in the intensive care unit. Russian Journal of Anaesthesiology and Reanimatology. 2013;(1):49–50. (In Russ.)
  11. Erpuleva YuV. Amino acids and microelements in parenteral nutrition in children. Lechashchij vrach. 2013;(3):51–54. (In Russ.)
  12. Kieft H, Roos AN, van Drunen JD, et al. Clinical outcome of immunonutrition in a heterogeneous intensive care population. Intensive Care Med. 2005;31(4):524–532. doi: 10.1007/s00134-005-2564-x
  13. Van den Berg A, Fetter WPF, Westerbeek EAM, et al. The effect of glutamine-enriched enteral nutrition on intestinal permeability in very-low-birth-weight infants: a randomized controlled trial. JPEN. 2006;30(5):408–414. doi: 10.1177/0148607106030005408
  14. Briassouli E, Briassoulis G. Glutamine randomized studies in early life: the unsolved riddle of experimental and clinical studies. Clin Dev Immunol. 2012;2012:1110–1117. doi: 10.1155/2012/749189
  15. Holecek M. Side effects of long-term glutamine supplementation. JPEN J Parenter Enteral Nutr. 2013;37(5):607–616. doi: 10.1155/2015/856091
  16. Griffiths RD, Allen KD, Andrews FJ, Jones C. Infection, multiple organ failure, and survival in the intensive care unit: influence of glutamine-supplemented parenteral nutrition on acquired infection. Nutrition. 2002;18(7-8):546–552. doi: 10.1016/s0899-9007(02)00817-1

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies